Key Takeaways BrainsWay invested $5M in Neurolief to enter the at-home mental health treatment market.Neurolief's Proliv Rx targets treatment-resistant depression and awaits FDA approval.The deal includes future milestone-based funding and a call option for full acquisition.BrainsWay Ltd. (BWAY) recently took a strategic step to expand its reach in the mental health market through a $5 million investment in Neurolief Ltd., a developer of wearable, non-invasive neuromodulation devices. The investment positio ...